Home › Free Stock Grades › IRON
Disc Medicine, Inc. (IRON) Stock Grade
IRON · Healthcare
B
Market Cap
$2.8B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Disc Medicine, Inc.'s fundamentals
Disc Medicine is a biotechnology company with a market capitalization of $2.8 billion that is not yet profitable, having reported a net loss in its latest annual statement with a net margin of 0.0%. The company generated no year-over-year revenue growth, indicating it is still in early development stages without meaningful commercial sales. As a pre-revenue or early-stage biotech firm, traditional valuation metrics like P/E ratio and return on equity are not applicable, and the company does not pay a dividend.